Managing Partner And Founder
CurrentASCIL Biopharm develops patented injectable and locally acting therapeutics with advanced drug delivery systems (DDS) - formulations and medical devices - to enhance the safety, effectiveness and conveniance of administration of drugs for chronic high burden diseases.The company's approach leverages the expertise of its highly experiencedd team, which has pioneered the development of commercial controlled release therapeutics, including peptides in long acting biodegradable and self-assembly DDS.ASCIL has has built a pipeline of patented products for licensing and has established collaborations with pharmaceutical companies to apply its integrated platform and know-how to their products.